Are peptides really worth it? What the science says

What did @nicolestroopnp actually say?

Nicole Stroop, a self-described functional medicine and peptide-certified nurse practitioner, made a strong personal claim: this peptide "has absolutely changed my life for anxiety." The peptide in question is Selank, a synthetic heptapeptide developed in Russia. She argues it works by modulating serotonin, dopamine, norepinephrine, and GABA, while also supporting brain-derived neurotrophic factor (BDNF) and reducing neuroinflammation. She listed candidate populations including people with anxiety, ADHD, PTSD, cognitive decline, and stress-related sleep issues. She closed with a reasonable caution: skip online sources and go through a compounding pharmacy via a qualified provider. That last part is good advice. The mechanistic claims in the middle, though, deserve a closer look.

Does the science back this up?

Partially, yes, but the evidence base is thin and almost entirely preclinical or from small Russian trials. Selank has real mechanistic data behind it, but calling it proven for anxiety in humans is a stretch at this stage of research.

Selank is a synthetic analog of tuftsin, and most of the published mechanistic work comes from Russian institutions, particularly the Institute of Molecular Genetics. Seredenin and Voronina (2009, Eksperimental'naya i Klinicheskaya Farmakologiya) documented anxiolytic effects in animal models with effects on serotonin and GABA-ergic tone. A small human trial by Zozulya et al. (2008, Bulletin of Experimental Biology and Medicine) showed reduced anxiety scores in patients with generalized anxiety disorder versus placebo, but the sample sizes were modest and independent replication is essentially nonexistent. The BDNF claim has some support from rodent studies showing Selank upregulates BDNF expression in hippocampal tissue, but translating that to human cognition and stress resilience is a significant inferential leap. Western peer-reviewed replications are sparse.

What did they get wrong (or right)?

Nicole got the general mechanism directionally correct but oversimplified it in ways that could mislead patients. She also made several candidate population claims that go well beyond what the current evidence supports.

What she got right: the serotonergic and GABAergic mechanisms are the most documented in available Selank literature. The GABA-modulatory effect, specifically its influence on GABA-A receptor sensitivity, is reasonably supported in preclinical work (Kolik et al., 2014, Bulletin of Experimental Biology and Medicine). Her sourcing advice, meaning compound pharmacy through a licensed provider, is genuinely correct and clinically responsible.

What she got wrong, or at least overstated:

• Calling serotonin "our happy neurotransmitter" is a persistent pop-science myth. Serotonin's role in mood is far more complex and contested than that framing suggests (Moncrieff et al., 2022, Molecular Psychiatry).
• Listing ADHD, PTSD, and cognitive decline as appropriate use cases goes beyond what any current clinical evidence for Selank supports. There are no robust human RCTs for Selank in these conditions.
• Describing dopamine as driving "focus and reward" as if this is straightforward ignores the complexity of dopaminergic circuits and may set unrealistic expectations.
• The anti-neuroinflammatory claim is plausible based on cytokine studies (Filatova et al., 2012, Russian Journal of Bioorganic Chemistry), but framing it as something that "directly" lowers inflammatory molecules causing neuroinflammation overstates certainty.

What should you actually know?

Selank is a genuinely interesting compound with a reasonable mechanistic rationale for anxiety. But interesting is not the same as proven, and this distinction matters when you are deciding whether to use it.

Here is what the honest picture looks like. Selank is not FDA-approved for any indication. It is available in the US only through compounding pharmacies operating under 503A or 503B frameworks, which means quality and sterility vary by pharmacy. The existing human trial data comes almost exclusively from Russian research groups with no independent replication in Western journals. That is not automatically disqualifying, but it means the evidence hierarchy is sitting at the bottom of the pyramid.

Personal testimonials from practitioners, even well-credentialed ones, are not a substitute for controlled trial data. Nicole saying it "absolutely changed my life" is her experience. It is not a clinical outcome measure. If you are considering Selank for anxiety, the reasonable move is a thorough conversation with a licensed provider who can assess your full clinical picture, not a TikTok comment asking for a protocol.

One thing Nicole did not address: Selank's tolerability profile. The available literature suggests it is generally well tolerated, but drug interactions and contraindications have not been studied adequately in diverse human populations. That gap matters.